bit.bio

bit.bio is a synthetic biology company focused on human cells that is advancing medicine (SDG9) and enabling curative treatments (SDG3). The company does this by industrialising the manufacture of human cells and making them more accessible. Our opti-ox™ precision cell programming and manufacturing technology enables conversion of induced pluripotent stem cells (iPSCs) into any desired human cell type in a single step. This can be achieved within days and at industrial scale, while maintaining exceptional purity and unparalleled consistency. Our discovery platform extends this approach to any desired cell type by identifying the transcription factor combinations that define cell states.